Status:
COMPLETED
Second eFramngham Heart Study
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
In the electronic Framingham Heart Study (eFHS), the investigators developed and deployed a mobile app to collect cardiovascular risk factors and event data and test them against cardiovascular data c...
Detailed Description
Participants in eFHS are invited to enroll from the FHS Offspring and Omni Group 1 Cohorts during the in-person examination 10/5 at the FHS Research Center in Framingham, Massachusetts (MA), USA or re...
Eligibility Criteria
Inclusion
- Invited to enroll from the FHS Offspring and Omni Group 1 Cohorts during the in-person examination 10/5 at the FHS Research Center
- English speaking
- English language reading proficiency
- Owns an iPhone with compatible iOS (version 10.0 or higher) or Android (version 5.0 or higher)
- Residence in the United States
- Provision of permissions for notifications and data sharing with the Research Center
- Provision of signed and dated informed consent (within the eFHS mobile app)
Exclusion
- Limited and non-readers
Key Trial Info
Start Date :
June 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2023
Estimated Enrollment :
492 Patients enrolled
Trial Details
Trial ID
NCT04752657
Start Date
June 21 2021
End Date
December 28 2023
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Framingham Heart Study
Framingham, Massachusetts, United States, 01702